SCHEMBL26035211

SCHEMBL26035211

Cc1ccc(NC(=O)c2ccc(N3CCN(C)[C@H](C)C3)nc2C)cc1-c1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF18A Q8NI77 1/20 0.49
ALB P02768 1/20 0.41
HTR1A P08908 1/20 0.41
SLC6A2 P23975 1/20 0.41
PDE4A P27815 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A3 Q01959 1/20 0.41
PDE4D Q08499 1/20 0.41
SHH Q15465 1/20 0.41
USP28 Q96RU2 1/20 0.41
SLC29A1 Q99808 1/20 0.41
SMO Q99835 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
RAF1 P04049 6/20 0.40
BRAF P15056 6/20 0.40
MAPT P10636 1/20 0.40
WDR5 P61964 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26035218 1.00 KIF18A (0.49) KIF18AALBHTR1ASLC6A2PDE4A
SCHEMBL26035205 1.00 KIF18A (0.49) KIF18AALBHTR1ASLC6A2PDE4A
SCHEMBL26035200 0.91 KIF18A (0.49) KIF18AALBHTR1ASLC6A2PDE4A
SCHEMBL26035237 0.89 KIF18A (0.53) KIF18AALBHTR1ASLC6A2PDE4A
SCHEMBL26037944 0.86 KIF18A (0.49) KIF18AALBHTR1ASLC6A2PDE4A
SCHEMBL26037949 0.85 KIF18A (0.51) KIF18AALBHTR1ASLC6A2PDE4A
SCHEMBL26037930 0.85 KIF18A (0.51) KIF18AALBHTR1ASLC6A2PDE4A
SCHEMBL26035242 0.84 KIF18A (0.52) KIF18AALBHTR1ASLC6A2PDE4A
SCHEMBL26037788 0.84 ALB (0.50) ALBHTR1ASLC6A2PDE4AOPRM1
SCHEMBL26035247 0.83 KIF18A (0.53) KIF18AALBHTR1ASLC6A2PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO KIF18A 3156/4885ALB 4881/4885HTR1A 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.